4498-67-3 | Indazole-3-carboxylic acid

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$8.00	$5.00
10g	98%	in stock	$9.00	$6.00
25g	98%	in stock	$19.00	$13.00
50g	98%	in stock	$33.00	$23.00
100g	98%	in stock	$48.00	$33.00

Description

• Catalog Number: AB46274
• Chemical Name: Indazole-3-carboxylic acid
• CAS Number: 4498-67-3
• Molecular Formula: C8H6N2O2
• Molecular Weight: 162.1454
• MDL Number: MFCD00211066
• SMILES: OC(=O)c1n[nH]c2c1cccc2
• NSC Number: 520610

Computed Properties

• Complexity: 196
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 1
• XLogP3: 1.4

Upstream Synthesis Route

1H-Indazole-3-carboxylic acid is a versatile compound that finds significant application in chemical synthesis, particularly in the field of medicinal chemistry. It serves as a key building block for the synthesis of various biologically active molecules and pharmaceuticals due to its unique structural features and reactivity.One of the primary uses of 1H-Indazole-3-carboxylic acid is in the synthesis of indazole derivatives, which are important scaffolds in drug discovery and development. By functionalizing the carboxylic acid group or other positions on the indazole ring, chemists can introduce specific properties or functionalities into the final molecule, thereby modulating its biological activity or pharmacokinetic profile.Furthermore, 1H-Indazole-3-carboxylic acid can be utilized in the preparation of heterocyclic compounds, which are commonly found in bioactive molecules such as antibiotics, antivirals, and anticancer agents. The presence of the indazole moiety imparts favorable characteristics to the resulting compounds, making them promising candidates for further pharmacological evaluation.In summary, the strategic incorporation of 1H-Indazole-3-carboxylic acid into synthetic pathways enables chemists to access a diverse array of bioactive compounds with potential therapeutic applications. Its role in chemical synthesis underscores its importance in the development of new drug candidates and other valuable products in the pharmaceutical industry.

Literature

• Hysteretic carbon dioxide sorption in a novel copper(II)-indazole-carboxylate porous coordination polymer.

  Chemical communications (Cambridge, England) 20121207

• High-affinity fluorescent ligands for the 5-HT(3) receptor.

  Bioorganic & medicinal chemistry letters 20120115

• Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.

  ChemMedChem 20120102

• Adjudin, a potential male contraceptive, exerts its effects locally in the seminiferous epithelium of mammalian testes.

  Reproduction (Cambridge, England) 20110501

• Stereocomplexes Formed From Select Oligomers of Polymer d-lactic Acid (PDLA) and l-lactate May Inhibit Growth of Cancer Cells and Help Diagnose Aggressive Cancers-Applications of the Warburg Effect.

  Perspectives in medicinal chemistry 20110101

• Quantum mechanical study and vibrational spectra of indazolium-3-carboxylate and its decarboxylation product, the N-heterocyclic carbene indazol-3-ylidene.

  Physical chemistry chemical physics : PCCP 20090114

• Fluorescent polycyclic ligands for nitric oxide synthase (NOS) inhibition.

  Bioorganic & medicinal chemistry 20081001

• [Treatment and post-treatment with lonidamine in human colon carcinoma HT-29 cell line].

  Medicina 20080101

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Electrospray ionization mass spectrometric studies of nucleophilic carbenes derived from pyrazolium and indazolium carboxylates.

  Rapid communications in mass spectrometry : RCM 20050101

• Clinical Evidence Supporting the Role of Lonidamine for the Treatment of BPH.

  Reviews in urology 20050101

• Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.

  Drugs of today (Barcelona, Spain : 1998) 20030301

• Characterization of the FAD-containing N-methyltryptophan oxidase from Escherichia coli.

  Biochemistry 20010206